BSE Live
Jun 28, 16:00Prev. Close
4.12
Open Price
3.95
Bid Price (Qty.)
4.07 (491)
Offer Price (Qty.)
4.33 (361)
NSE Live
Jun 28, 15:57Prev. Close
4.20
Open Price
4.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4.20 (50)
| Key Financial Ratios of Syncom Healthcare (in Rs. Cr.) | Mar 21 | Mar 20 | Mar 19 | Mar 18 | Mar 17 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -1.23 | -2.88 | -2.83 | -16.38 | -19.47 | |
| Diluted EPS (Rs.) | -1.23 | -2.88 | -2.83 | -16.38 | -19.47 | |
| Cash EPS (Rs.) | -0.73 | -2.36 | -2.11 | -15.45 | -18.30 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | -4.33 | -3.10 | -0.23 | 2.62 | 19.02 | |
| Book Value [InclRevalReserve]/Share (Rs.) | -4.33 | -3.10 | -0.23 | 2.62 | 19.02 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 0.46 | 4.99 | 14.27 | 10.38 | 13.21 | |
| PBDIT/Share (Rs.) | -0.73 | -0.39 | -0.38 | -1.19 | 0.00 | |
| PBIT/Share (Rs.) | -1.23 | -0.96 | -1.11 | -2.13 | -1.15 | |
| PBT/Share (Rs.) | -1.23 | -2.93 | -2.84 | -16.38 | -17.48 | |
| Net Profit/Share (Rs.) | -1.23 | -2.93 | -2.84 | -16.38 | -19.45 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -159.29 | -7.85 | -2.65 | -11.48 | -0.01 | |
| PBIT Margin (%) | -268.02 | -19.32 | -7.79 | -20.49 | -8.73 | |
| PBT Margin (%) | -267.97 | -58.69 | -19.92 | -157.77 | -132.29 | |
| Net Profit Margin (%) | -267.97 | -58.69 | -19.92 | -157.77 | -147.25 | |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 0.00 | -625.76 | -102.28 | |
| Return on Capital Employed (%) | 94.05 | 990.02 | -39.34 | -54.31 | -5.45 | |
| Return on Assets (%) | -29.96 | -65.74 | -22.99 | -107.64 | -66.30 | |
| Total Debt/Equity (X) | -1.40 | -1.91 | -26.49 | 1.72 | 0.30 | |
| Asset Turnover Ratio (%) | 0.11 | 112.01 | 115.39 | 68.22 | 45.02 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.26 | 0.26 | 0.90 | 0.94 | 1.55 | |
| Quick Ratio (X) | 0.24 | 0.15 | 0.72 | 0.73 | 1.22 | |
| Inventory Turnover Ratio (X) | 1.77 | 9.92 | 8.04 | 4.36 | 4.89 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 25.44 | 30.67 | 35.73 | 45.30 | |
| EV/Net Operating Revenue (X) | 0.00 | 1.27 | 0.54 | 0.86 | 0.86 | |
| EV/EBITDA (X) | 0.00 | -16.22 | -20.26 | -7.49 | -4,356.17 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.15 | 0.14 | 0.44 | 0.43 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | -0.24 | -9.07 | 1.75 | 0.30 | |
| Price/Net Operating Revenue | 0.00 | 0.15 | 0.14 | 0.44 | 0.43 | |
| Earnings Yield | 0.00 | -4.01 | -1.39 | -3.58 | -3.39 |
16.02.2021
Syncom Health Standalone December 2020 Net Sales at Rs 0.45 crore, down 52.8% Y-o-Y
02.07.2020
Kotak Mahindra International offloads stake in KRBL, Alpha Leon buys shares in McLeod Russel
26.06.2020
Syncom Health Standalone March 2020 Net Sales at Rs 0.15 crore, down 98.71% Y-o-Y
16.11.2018
Syncom Health Standalone September 2018 Net Sales at Rs 14.97 crore, up 19.53% Y-o-Y
10.04.2026
09.04.2026
08.04.2026
Indian CDMOs face tariff exposure via patented drug supply chains
08.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth